Brochure
21 May 2026
Minerva Biolabs Company Brochure
PDF 6.4 MB
Discover Minerva Biolabs’ portfolio of mycoplasma detection and cell culture contamination control solutions for pharmaceutical, biotechnology, and research applications.
Content provided by our supplier
Minerva Biolabs GmbH
-
Country/Region:Germany
-
Founded:1999
-
On CPHI since:2026
-
Certificates:1
-
Employees:25 - 49
Company types
Primary activities
Other Content from Minerva Biolabs GmbH (1)
-
News Minerva Biolabs Supports Compliance with the Updated EP 2.6.7 Requirements
The revised EP 2.6.7 chapter introduces new expectations for NAT-based mycoplasma testing. With validated PCR assays, extraction kits, and reference standards, Minerva Biolabs offers comprehensive solutions to help laboratories efficiently implement and validate compliant workflows according to the latest European Pharmacopoeia requirements.